Loading clinical trials...
Loading clinical trials...
Study objective is to investigate the safety and effectiveness of long-term daily use of JARDIANCE® Tablets in patients with chronic heart failure (CHF) under real-world use.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Boehringer Ingelheim
Collaborators
NCT03999138 · Acute Heart Failure, Pulmonary Edema With Heart Failure
NCT03103932 · Heart Failure; With Decompensation
NCT06762964 · Fontan Circulation, Single Ventricle Heart Disease, and more
NCT04347655 · Heart Failure
NCT07083011 · Heart Failure With Preserved Ejection Fraction
Nippon Boehringer Ingelheim Co., Ltd.
Tokyo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions